Box S1. Current diagnostics for TB.
Replacement BCG vaccination
Recombinant BCG overexpressing Ag85B -rBCG30; UCLA, Aeras
Boosting existing BCG vaccination
Recombinant fusion protein Mtb72f ( Box S5. Basis of multiplex cytokine determination.
Box S5 Legend:
Luminex xMAP technology is a sensitive multiplex assay platform for simultaneous measurements of multiple analytes in a qualitative and quantitative way. The system utilizes 5.6µ polysterene microspheres as solid support for a conventional immunosorbent assay which is internally dyed with a blend of red and infrared fluorophore. Using different intensities of two dyes for different batches of microspheres, 100 xMAP microsphere sets can be created, each with a unique spectral signature determined by its red/infrared mixture allowing simultaneous measurements in a single reaction volume. Unique color-coded beads are coated with capture antibodies which bind to the analytes when samples are added to the well with these beads. Fluorescence-labelled reporter antibodies bind to the capture analytes. Bead identifier and reporter quantity are determined by laser detectors.
Box S6 Legend. Unique multiplex ligation probe amplification (MLPA) probes of specific size are designed for each target sequence. The MLPA assay starts with hybridization of the synthetic probe mix to a cDNA sample. After binding of both probes to their respective targets, the probes are ligated using a thermostable ligase. A universal primer pair (X and Y, one of them being labeled with a fluorochrome) is then used to amplify all ligated probes. Resulting labeled PCR fragments all have a unique size, allowing identification of each product on a gel or automated sequencing machine. Peak areas of each PCR product correspond to the initial number of target cDNA molecules in the sample.
